Diagnosis and Product Attribution Trigger Accrual Under Georgia Law: Limits on the Discovery Rule and the Independent Bar of the 10-Year Statute of Repose

1. Introduction

In James Brown v. E.T. Browne Drug Company (11th Cir. Apr. 23, 2026) (per curiam) (not for publication), the Eleventh Circuit affirmed the dismissal of a pro se diversity products-liability action as untimely under Georgia law. The plaintiff, James Brown, alleged that E.T. Browne Drug Company’s hydroquinone “Fade Cream” caused him to suffer exogenous ochronosis (a skin-darkening condition). The core dispute on appeal was accrual: when Brown’s “right of action” accrued for purposes of Georgia’s two-year limitations period for personal injuries, and whether a “discovery rule” theory could toll or delay accrual.

The decision also addressed (i) the Rule 12(b)(6) use of medical records attached to a motion to dismiss under the “incorporation by reference” doctrine and (ii) Georgia’s 10-year statute of repose for strict-liability claims against manufacturers.

2. Summary of the Opinion

The Eleventh Circuit held that Brown’s complaint was time-barred on its face because:

  • Brown’s injury was discovered/diagnosed in 2021, and Georgia’s two-year personal-injury statute of limitations (O.C.G.A. § 9-3-33) therefore expired in 2023.
  • Brown filed suit on November 14, 2024—well after the two-year period measured from November 18, 2021 (the date shown by medical records and Brown’s own concession).
  • Brown’s “discovery rule” tolling argument failed because the record indicated he suspected the product’s role in 2021, and Georgia limits the discovery rule to particular categories of injuries developing over time; in any event, the facts here were apparent to a reasonable person in 2021.
  • To the extent Brown invoked the “ten-year statute of repose,” it independently barred strict-liability claims because he began using the product more than ten years before filing suit.

Accordingly, the district court’s dismissal was affirmed.

3. Analysis

3.1. Precedents Cited

(a) Standards of review and Rule 12(b)(6) framework

  • Foudy v. Indian River Cnty. Sheriff's Off., 845 F.3d 1117, 1122 (11th Cir. 2017): The court relied on Foudy for de novo review of “interpretation and application of a statute of limitations,” framing timeliness as a legal question appropriate for appellate reassessment.
  • United States v. Henco Holding Corp., 985 F.3d 1290, 1296 (11th Cir. 2021): Cited for the proposition that if a complaint shows claims are time-barred on its face, dismissal under Rule 12(b)(6) is proper. This is critical because the panel treated timeliness as resolvable at the pleading stage, not requiring discovery.
  • Welch v. Celotex Corp., 951 F.2d 1235, 1237 (11th Cir. 1992): Quoted for the rule that, on dispositive motions, the record and inferences are viewed in the light most favorable to the non-movant; later, Welch also served as the key comparator for discovery-rule timing in latent-injury contexts.
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007), and Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009): These cases supplied the plausibility standard governing whether allegations suffice to proceed past dismissal, reinforcing that a plaintiff must plead facts that plausibly support timely filing (or tolling).
  • Horsley v. Feldt, 304 F.3d 1125, 1134 (11th Cir. 2002): The panel used Horsley to justify considering medical records attached to the motion to dismiss under the “incorporation by reference” doctrine, because they were “central” to the claim and “undisputed” (authenticity not challenged). This was pivotal to pinning down November 18, 2021 as the operative timing datum.

(b) Erie, substantive limitation rules, and Georgia’s governing time bars

  • Erie R.R. Co. v. Tompkins, 304 U.S. 64, 78 (1938): Provided the baseline that state substantive law controls in diversity. The panel used Erie to anchor the choice of Georgia accrual and limitations doctrines.
  • Cambridge Mut. Fire Ins. Co. v. Claxton, 720 F.2d 1230, 1232 (11th Cir. 1983): Cited for the specific point that statutes of limitations are substantive for diversity purposes, so Georgia’s limitation rules govern.
  • Smith, Miller & Patch v. Lorentzson, 327 S.E. 2d 221, 222 (Ga. 1985): Cited to confirm that Georgia’s two-year personal injury limitations period (O.C.G.A. § 9-3-33) governs product-liability claims involving personal injury.
  • Everhart v. Rich's, Inc., 194 S.E. 2d 425, 428 (Ga. 1972): This Georgia Supreme Court decision supplied the primary accrual rule applied: in personal injury actions, the statute of limitations begins “at the time the damage or injury is actually sustained.” The panel treated Brown’s 2021 discovery/diagnosis as the point by which injury was “actually sustained” for limitations purposes.
  • Waters v. Rosenbloom, 490 S.E. 2d 73, 75 (Ga. 1997): Cited for Georgia’s articulation of the discovery rule in “continuous tort” contexts—accrual when the plaintiff discovers (or should discover) both injury and cause. The panel used Waters to reject tolling because Brown’s own statements and records indicated he connected his symptoms to the product in 2021.
  • M.H.D. v. Westminster Sch., 172 F.3d 797, 804 (11th Cir. 1999) (quoting Corp. of Mercer Univ. v. Nat'l Gypsum Co., 368 S.E. 2d 732, 733 (Ga. 1988)): These cases were invoked to emphasize that the Georgia Supreme Court has “explicitly limited the discovery rule’s application” to bodily injury cases developing over an extended period. The panel used that limitation to narrow the availability of discovery-rule tolling in Brown’s circumstances.

(c) Pro se construction and appellate forfeiture

  • Timson v. Sampson, 518 F.3d 870, 874 (11th Cir. 2008): The panel applied Timson both to (i) liberally construe pro se filings and (ii) deem issues not briefed abandoned. This mattered for Brown’s underdeveloped arguments (including an undeveloped repose argument).
  • Campbell v. Air Jam. Ltd., 760 F.3d 1165, 1169 (11th Cir. 2014): Cited to underscore the limit of liberal construction—courts may not rewrite deficient pleadings to rescue an action.

(d) The comparator case: why Welch did not help Brown

The opinion’s most fact-driven precedent analysis centers on Welch v. Celotex Corp.. In Welch, the Eleventh Circuit reversed summary judgment because—viewing the evidence favorably to the plaintiff—a jury could find the plaintiff did not and should not have known that a manufacturer’s wrongful conduct caused his injury until later (after attorney consultation). The present panel distinguished Welch on a key factual axis: Brown’s own records reflected that, in 2021, he already suspected the hydroquinone product’s role in his discoloration and potential ochronosis. Thus, the “unknown tortfeasor involvement” dynamic that preserved timeliness in Welch was absent here.

3.2. Legal Reasoning

(a) Accrual under O.C.G.A. § 9-3-33: injury sustained and known in 2021

Applying Everhart v. Rich's, Inc., the court treated accrual as triggered when Brown’s injury was “actually sustained.” The panel relied on two mutually reinforcing sources establishing 2021 as the relevant time:

  • Brown’s own concession in the district court that the permanent injury “was discovered and diagnosed in the year 2021 by medical professionals.”
  • Medical records showing that on November 18, 2021 Brown presented with dark discoloration after years of hydroquinone use and suspected exogenous ochronosis.

From that, the court performed a straightforward limitations calculation: two years from November 18, 2021 expired on November 18, 2023; Brown filed on November 14, 2024; therefore the suit was untimely absent tolling.

(b) Pleading-stage use of medical records: Horsley incorporation by reference

Brown argued the district court improperly credited the defendant’s evidence (his medical records) at the motion-to-dismiss stage and raised concerns about redactions. The panel rejected both points by applying Horsley v. Feldt: documents attached to a motion to dismiss may be considered if “central” and “undisputed.” Here, medical records were central to the questions of injury, diagnosis, and timing—and Brown did not challenge their authenticity. Redactions for privacy did not undermine the analysis, and the later-submitted unredacted version did not change the accrual conclusion.

(c) Discovery rule / continuous tort: not available on these facts

Brown sought tolling until a later “date of loss” (December 8, 2022). The court rejected this because:

  • Brown conceded diagnosis/discovery in 2021, undercutting any claim that he lacked awareness of injury.
  • The medical record evidence indicated he suspected the causal connection to hydroquinone in 2021, undercutting lack of awareness of cause.
  • Under M.H.D. v. Westminster Sch. (quoting Corp. of Mercer Univ. v. Nat'l Gypsum Co.), Georgia limits discovery-rule use; and even under the Waters v. Rosenbloom formulation, a reasonable person would have discovered injury and cause in 2021 given Brown’s symptoms and his expressed suspicion.

The court’s reasoning is best understood as a “two-key” accrual test in practice: once the plaintiff is aware (or should be aware) of both (1) injury and (2) the product/cause, the clock runs. Here, both keys turned in 2021.

(d) Statute of repose: an independent strict-liability bar

The panel also addressed Brown’s reference to a “ten-year statute of repose,” construing it as Georgia’s strict-liability repose rule for manufacturers (O.C.G.A. § 51-1-11(b)(2)) requiring suit within ten years of the product’s first sale for use or consumption. While Brown did not cite the statute, the court addressed it and concluded it did not help him: Brown stated he began using the product at age 15, and his 2021 records listed him as age 33—meaning his use began more than ten years before suit. On those facts, strict liability would be time-barred by repose regardless of the two-year limitations analysis.

3.3. Impact

Although designated “not for publication” and therefore not intended as binding precedent, the decision is instructive in at least four recurring litigation scenarios in Georgia-based diversity product cases:

  • Timeliness can be resolved at the pleading stage when the complaint, concessions, or incorporated documents establish accrual and filing dates (United States v. Henco Holding Corp.).
  • Medical records may fix accrual at Rule 12(b)(6) under Horsley v. Feldt, particularly where diagnosis timing and suspected causation appear in those records and authenticity is not disputed.
  • Discovery-rule arguments must grapple with Georgia’s narrow scope as framed by M.H.D. v. Westminster Sch. and Corp. of Mercer Univ. v. Nat'l Gypsum Co., and must plausibly allege why injury-and-cause were not reasonably discoverable earlier.
  • Statute of repose is a separate gatekeeper: even if a plaintiff could extend accrual for limitations, O.C.G.A. § 51-1-11(b)(2) can independently extinguish strict-liability claims after the repose period.

4. Complex Concepts Simplified

  • Statute of limitations: a deadline to file suit that typically starts when the claim “accrues” (under Georgia personal-injury law, when the injury is sustained—Everhart v. Rich's, Inc.).
  • Accrual: the moment the law treats your claim as having come into existence, starting the limitations clock. In this opinion, accrual was effectively tied to the 2021 diagnosis and the plaintiff’s suspicion of the product’s role.
  • Discovery rule: a doctrine that can delay accrual until the plaintiff discovers (or should discover) both the injury and its cause (Waters v. Rosenbloom), but Georgia limits its availability in bodily-injury cases (M.H.D. v. Westminster Sch. quoting Corp. of Mercer Univ. v. Nat'l Gypsum Co.).
  • Continuous tort: a wrongful course of conduct producing injury over time; sometimes linked to the discovery rule. The court treated Brown’s facts as not supporting delayed discovery because injury and cause were apparent in 2021.
  • Statute of repose: an absolute cutoff tied to a product-related event (here, first sale for use/consumption), which can bar claims even if the injury is discovered later (O.C.G.A. § 51-1-11(b)(2)).
  • Incorporation by reference: a Rule 12(b)(6) practice allowing courts to consider certain documents attached to a motion to dismiss (if central and undisputed) without converting the motion into summary judgment (Horsley v. Feldt).

5. Conclusion

The Eleventh Circuit’s affirmance rests on a straightforward but consequential timing principle: under Georgia law, once a plaintiff has (or should have) awareness of both injury and its product-related cause—as reflected here by a 2021 medical visit, suspected diagnosis, and the plaintiff’s own concession—the two-year limitations clock in O.C.G.A. § 9-3-33 runs, and later “date of loss” labels do not reset it. The opinion further illustrates how Horsley v. Feldt enables courts to use undisputed, central medical records at the pleading stage to decide timeliness, and it reinforces that Georgia’s 10-year statute of repose (O.C.G.A. § 51-1-11(b)(2)) can independently extinguish strict-liability claims regardless of discovery.